311 related articles for article (PubMed ID: 12080348)
21. [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice].
Merz H; Lange K; Nadrowitz R; Uckert W; Blankenstein T; Feller AC
Verh Dtsch Ges Pathol; 2003; 87():224-31. PubMed ID: 16888916
[TBL] [Abstract][Full Text] [Related]
22. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
[TBL] [Abstract][Full Text] [Related]
24. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
[TBL] [Abstract][Full Text] [Related]
25. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
[TBL] [Abstract][Full Text] [Related]
26. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
Sjostrom C; Seiler C; Crockett DK; Tripp SR; Elenitoba Johnson KS; Lim MS
Exp Hematol; 2007 Aug; 35(8):1240-8. PubMed ID: 17560012
[TBL] [Abstract][Full Text] [Related]
27. Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase.
Turner SD; Tooze R; Maclennan K; Alexander DR
Oncogene; 2003 Oct; 22(49):7750-61. PubMed ID: 14586401
[TBL] [Abstract][Full Text] [Related]
28. Nucleophosmin sets a threshold for p53 response to UV radiation.
Maiguel DA; Jones L; Chakravarty D; Yang C; Carrier F
Mol Cell Biol; 2004 May; 24(9):3703-11. PubMed ID: 15082766
[TBL] [Abstract][Full Text] [Related]
29. Polyamine depletion induces nucleophosmin modulating stability and transcriptional activity of p53 in intestinal epithelial cells.
Zou T; Rao JN; Liu L; Marasa BS; Keledjian KM; Zhang AH; Xiao L; Bass BL; Wang JY
Am J Physiol Cell Physiol; 2005 Sep; 289(3):C686-96. PubMed ID: 15872011
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
[TBL] [Abstract][Full Text] [Related]
31. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
[TBL] [Abstract][Full Text] [Related]
32. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
Kim JY; Cho YE; Park JH
Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
[TBL] [Abstract][Full Text] [Related]
33. Nucleophosmin: a versatile molecule associated with hematological malignancies.
Naoe T; Suzuki T; Kiyoi H; Urano T
Cancer Sci; 2006 Oct; 97(10):963-9. PubMed ID: 16984370
[TBL] [Abstract][Full Text] [Related]
34. Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response.
Kurki S; Peltonen K; Laiho M
Cell Cycle; 2004 Aug; 3(8):976-9. PubMed ID: 15254398
[TBL] [Abstract][Full Text] [Related]
35. The N-terminal half of NPM dissociates from nucleoli of HeLa cells after anticancer drug treatments.
Chan PK; Bloom DA; Hoang TT
Biochem Biophys Res Commun; 1999 Oct; 264(1):305-9. PubMed ID: 10527882
[TBL] [Abstract][Full Text] [Related]
36. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
37. Nucleophosmin and human cancer.
Lim MJ; Wang XW
Cancer Detect Prev; 2006; 30(6):481-90. PubMed ID: 17113241
[TBL] [Abstract][Full Text] [Related]
38. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
Li Z; Boone D; Hann SR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
[TBL] [Abstract][Full Text] [Related]
39. The Myc-nucleophosmin-ARF network: a complex web unveiled.
Li Z; Hann SR
Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
[TBL] [Abstract][Full Text] [Related]
40. Nucleophosmin blocks mitochondrial localization of p53 and apoptosis.
Dhar SK; St Clair DK
J Biol Chem; 2009 Jun; 284(24):16409-16418. PubMed ID: 19366707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
